(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-25 View latest technical analysis
10 day averaged volume of Logicbio Therapeutics is 174380
Date | Daily Closing Price | Open | High | Low | Volume |
25 Tue Feb 2025 | 8.63 | 7.70 | 8.67 | 7.34 | 8.094 times |
24 Mon Feb 2025 | 7.22 | 7.56 | 7.60 | 7.21 | 1.215 times |
21 Fri Feb 2025 | 7.54 | 7.75 | 7.78 | 7.52 | 1.005 times |
20 Thu Feb 2025 | 7.76 | 7.88 | 7.88 | 7.64 | 0.778 times |
19 Wed Feb 2025 | 7.82 | 7.82 | 7.93 | 7.75 | 0.826 times |
18 Tue Feb 2025 | 7.89 | 7.88 | 7.93 | 7.76 | 1.124 times |
14 Fri Feb 2025 | 7.94 | 8.28 | 8.28 | 7.90 | 0.781 times |
13 Thu Feb 2025 | 8.22 | 7.96 | 8.32 | 7.96 | 1.496 times |
12 Wed Feb 2025 | 7.95 | 7.69 | 8.02 | 7.64 | 1.188 times |
11 Tue Feb 2025 | 7.79 | 7.76 | 7.81 | 7.64 | 0.684 times |
Stock of Logicbio Therapeutics (LOGC) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 8.5, for a target of 8.1 or 7.79
Share price targets for Logicbio Therapeutics (LOGC)
Target Type | Value |
Downside Target | 5.35 |
Downside Target | 6.03 |
Downside Target | 6.29 |
Downside Target | 6.43 |
Downside Target | 6.72 |
Downside Target | 6.86 |
Downside Target | 7.21 |
Downside Target | 7.52 |
Downside Target | 7.80 |
Downside Target | 8.11 |
Downside Target | 8.21 |
Downside Target | 8.32 |
Upside Target | 8.67 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
Target Type | Value |
Downside Intraday Target | 7.67 |
Downside Intraday Target | 6.71 |
Upside Intraday Target | 9.13 |
Upside Intraday Target | 9.63 |
Downside Intraday Target | 8.17 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
Date | Weekly Closing Price | Open | High | Low | Volume |
25 Tue Feb 2025 | 8.63 | 7.56 | 8.67 | 7.21 | 2.494 times |
21 Fri Feb 2025 | 7.54 | 7.88 | 7.93 | 7.52 | 0.739 times |
14 Fri Feb 2025 | 7.94 | 7.72 | 8.32 | 7.60 | 0.785 times |
07 Fri Feb 2025 | 7.72 | 7.60 | 8.11 | 7.53 | 1.432 times |
31 Fri Jan 2025 | 7.77 | 6.97 | 7.80 | 6.86 | 1.299 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
Date | Monthly Closing Price | Open | High | Low | Volume |
25 Tue Feb 2025 | 8.63 | 7.60 | 8.67 | 7.21 | 1.152 times |
31 Fri Jan 2025 | 7.77 | 7.08 | 7.80 | 6.29 | 0.99 times |
31 Tue Dec 2024 | 7.03 | 7.98 | 8.21 | 6.43 | 0.702 times |
26 Tue Nov 2024 | 7.10 | 6.47 | 7.25 | 6.03 | 0.748 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Logicbio Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.19 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Logicbio Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Logicbio Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Logicbio Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.19 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.